Podocon 25

Manufacturer
Bryant Ranch Prepack
Effective date
2025-10-21
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
100
Source
full-release
Hydrated at
2026-05-31 22:02:34

Label at a glance#

ProductPodocon 25
Active ingredientPODOPHYLLUM RESIN
Label structure10 sections

Dosage and administration

PODOCON-25 ® IS TO BE APPLIED ONLY BY A PHYSICIAN. IT IS NOT TO BE DISPENSED TO THE PATIENT. SHAKE WELL. Thoroughly cleanse affected area. Use supplied applicator to apply Podocon-25 ® sparingly to lesion. Avoid contact with healthy tissue. Allow to dry thoroughly. Only intact (no bleeding) lesions should be treated. As podophyllin is a powerful caustic and severe irritant, it is recommended the first application ...

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

Podocon-25® is composed of Podophyllin (Podophyllum Resin, American) 25% in Benzoin Tincture. Podophyllum Resin is the powdered mixture of resins removed from the May apple or Mandrake (Podophyllum peltatum Linne’), a perennial plant of northern and middle United States(1). The podophyllin resin used in this product is exclusively the American podophyllin (rather than the Indian resin). American podophyllin typically has a reduced level of podophyllotoxin (see below).

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Podophyllin is a cytotoxic agent that has been used topically in the treatment of genital warts. It arrests mitosis in metaphase, an effect it shares with other cytotoxic agents such as the vinca alkaloids(2). The active agent is podophyllotoxin, whose concentration varies with the type of podophyllin used; the American source normally containing one-fourth the amount of podophyllotoxin as the Indian source(3).

NOTE: PODOCON-25®IS TO BE APPLIED ONLY BY A PHYSICIAN. IT IS NOT TO BE DISPENSED TO THE PATIENT.

INDICATIONS:

INDICATIONS & USAGE SECTION

Podocon-25® (25% podophyllin in benzoin tincture) is indicated for the removal of soft genital (venereal) warts (condylomata acuminata)(4).

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Podocon-25® is contraindicated in diabetics, patients using steroids or with poor blood circulation. Podocon-25® should not be used on bleeding warts, moles, birthmarks or unusual warts with hair growing from them. It is recommended that Podocon-25® not be used during pregnancy (see Pregnancy warning below).

WARNINGS:

WARNINGS SECTION

Podophyllin is a powerful caustic and severe irritant. Keep away from the eyes; if eye contact occurs, flush with copious amounts of warm water and consult physician or poison control center immediately for advice.

PRECAUTIONS:

PRECAUTIONS SECTION

Do not use Podocon-25® if wart or surrounding tissue is inflamed or irritated. Do not use on bleeding warts, moles, birthmarks or unusual warts with hair growing from them.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

The use of topical podophyllin has been known to result in paresthesia, polyneuritis, paralytic ileus, pyrexia, leukopenia, thrombocytopenia, coma and death(5).

Pregnancy:

PREGNANCY SECTION

There have been reports of complications associated with the topical use of podophyllin on condylomata of pregnant patients including birth defects, fetal death and stillbirth(6). In the absence of controlled safety studies, podophyllin remains contraindicated for use on pregnant patients.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known whether podophyllin is excreted in human milk following topical application. In the absence of controlled safety studies, podophyllin remains contraindicated for use on nursing patients.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

PODOCON-25®IS TO BE APPLIED ONLY BY A PHYSICIAN. IT IS NOT TO BE DISPENSED TO THE PATIENT. SHAKE WELL. Thoroughly cleanse affected area. Use supplied applicator to apply Podocon-25®sparingly to lesion. Avoid contact with healthy tissue. Allow to dry thoroughly. Only intact (no bleeding) lesions should be treated. As podophyllin is a powerful caustic and severe irritant, it is recommended the first application of Podocon-25® be left in contact for only a short time (30-40 minutes) to determine patient’s sensitivity. To avoid systemic absorption, time of contact should be minimum time necessary to produce the desired result (1 to 4 hours, depending on condition of lesion and of patient), the physician developing his/her own experience and technique. Large areas or numerous warts should not be treated at once.

After treatment time has elapsed, remove dried Podocon-25® thoroughly with alcohol or soap and water.

HOW SUPPLIED:

HOW SUPPLIED SECTION

Podocon-25® is available in 15-mL bottles with tapered tip applicator attached inside cap.

NDC: 71335-2925-1: 15 mL in a BOTTLE, WITH APPLICATOR

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] in tight, light-resistant containers.

Repackaged/Relabeled by:
Bryant Ranch Prepack, Inc.
Burbank, CA 91504

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Podophyllum Resin 25% Tincture #15

Label
Label

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 1287133529251lbl713352925.jpg
Data codeData Matrix0100363629103317211444981724013110LOT42832lbl713352925.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71335-2925-1Podocon 2515 mL in 1 BOTTLE, WITH APPLICATORTINCTURE15100
71335-2925-1Podocon 251 in 1 CARTONTINCTURE1100

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71335-2925-1ML - Milliliter71335-29255336ac18-9505-4ced-adff-5d33136f3e1512025-12-16
0574-0601-15ML - Milliliter0574-0601101cce12-461e-4120-b8c0-d6533f27580412014-10-03

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71335-292571335-2925-1
0574-0601

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Podocon 25PODOPHYLLUM RESINBryant Ranch Prepack790711b3-2168-4a19-b5c9-e46bf06143f62025-10-21Warnings, Adverse reactionsExact identifier
ndc (package): 71335-2925-1
ndc (product): 71335-2925
ndc11 (package): 71335292501
spl id: c4e909ba-10b5-4c09-afea-4c5d151f657a
spl set id: 790711b3-2168-4a19-b5c9-e46bf06143f6
Podocon 25PODOPHYLLUM RESINPadagis US LLCde96dc6e-e6d1-4383-9ce1-4d06bac08e002022-06-30Warnings, Adverse reactionsExact identifier
ndc (product): 0574-0601

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.